Growth Metrics

Pacific Biosciences Of California (PACB) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 35.62%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 35.62%
Dec 31, 2025 -31.34%
Sep 30, 2025 -29.48%
Jun 30, 2025 34.25%
Mar 31, 2025 2.46%
Dec 31, 2024 -3.96%
Jun 30, 2024 29.40%
Mar 31, 2024 -83.49%
Dec 31, 2023 12.24%
Sep 30, 2023 79.75%
Jun 30, 2023 -225.49%
Mar 31, 2023 -10.12%
Dec 31, 2022 194.69%
Sep 30, 2022 39.97%
Jun 30, 2022 -113.39%
Mar 31, 2022 3.45%
Dec 31, 2021 140.59%
Jun 30, 2021 -241.42%
Mar 31, 2021 45.09%
Dec 31, 2020 -123.89%
Sep 30, 2020 -146.80%
Jun 30, 2020 59.36%
Mar 31, 2020 -60.47%
Dec 31, 2019 -35.92%
Sep 30, 2019 21.86%
Jun 30, 2019 41.83%
Mar 31, 2019 53.75%
Dec 31, 2018 37.36%
Sep 30, 2018 -65.87%
Jun 30, 2018 118.42%
Mar 31, 2018 -35.84%
Dec 31, 2017 108.60%
Sep 30, 2017 -27.28%
Jun 30, 2017 -521.40%
Mar 31, 2017 45.94%
Dec 31, 2016 31.54%
Sep 30, 2016 42.40%
Jun 30, 2016 -8.63%
Mar 31, 2016 -60.87%
Dec 31, 2015 -39.19%
Sep 30, 2015 -2.88%
Jun 30, 2015 18.12%
Mar 31, 2015 5.64%
Dec 31, 2014 -27.97%
Sep 30, 2014 -18.07%
Jun 30, 2014 27.46%
Mar 31, 2014 31.50%
Dec 31, 2013 34.89%
Sep 30, 2013 51.81%